News
ICN2 Plasmonic Biosensor for COVID and other conditions [02-03-2022]
An innovative nano-biosensor assay for fast, quantitative and accurate COVID-19 serology, has been developed by a team of researchers led by Prof. Laura M. Lechuga, head of the NanoBiosensors and Bioanalytical Applications Group at the Catalan Institute of Nanoscience and Nanotechnology (ICN2, Barcelona, Spain). The sensor combines the high reliability of specialised laboratory analysis with the short turnaround times and simple operability of rapid self-tests.
Related News
Josep Samitier joins Fraunhofer Spain Research as Director [19-01-2026]
Nanobiotechnology, Nanomedicine, Scientific Policy
Nanoparticle therapy reprograms tumor immune cells to attack cancer from within [02-01-2026]
Nanobiotechnology, Nanomedicine
Nanozigzags, a new biomaterial, can enhance cancer immunotherapy efficacy by nearly 70% [30-12-2025]
Nanobiotechnology, Nanomedicine
Josep Samitier concludes thirteen years at the helm of IBEC [17-12-2025]
Nanobiotechnology, Scientific Policy
Nanorobot hand made of DNA grabs viruses for diagnostics and blocks cell entry [27-11-2024]
Nanobiotechnology, Nanomedicine
CLOSE
Sitemap
  NEWS
  CONFERENCES
  JOBS
  PH REPORTS

© Phantoms Foundation 2026